Clinical Trials Logo

Advanced Prostate Cancer clinical trials

View clinical trials related to Advanced Prostate Cancer.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03651271 Completed - Clinical trials for Advanced Prostate Cancer

Nivolumab With or Without Ipilimumab in Advanced Metastatic Cancer

Start date: October 17, 2018
Phase: Phase 2
Study type: Interventional

This is an open-label, exploratory study to evaluate nivolumab with or without ipilimumab based on percentage of tumoral CD8 cells at the time of treatment in participants with varying advanced solid tumors. Participants who have a tumor with ≥ 15% CD8 cells (classified as CD8 high) will receive nivolumab monotherapy, and participants who have a tumor with < 15% CD8 cells (classified as CD8 low) will receive ipilimumab in combination with nivolumab.

NCT ID: NCT02234089 Completed - Clinical trials for Advanced Prostate Cancer

Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasing-Hormone (LHRH) Agonists.

ProComD
Start date: September 2014
Phase:
Study type: Observational

The purpose of this study is to detect factors influencing decision making for treatment pathways of hormone-naïve prostate cancer patients with and without comorbidities receiving medicinal androgen deprivation therapy (Degarelix or LHRH agonists).

NCT ID: NCT01383863 Completed - Clinical trials for Advanced Prostate Cancer

A Long-term Observational Study Cohort in Patients With Advanced Prostate Cancer

TRIPTOCARE LT
Start date: October 2011
Phase:
Study type: Observational

The purpose of the protocol is to assess the rate of castration resistance, disease progression and overall survival over a 3-year period post-androgen deprivation therapy (ADT) induction in a study cohort of patients with advanced disease.

NCT ID: NCT01306890 Completed - Prostatic Neoplasms Clinical Trials

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

PROCEED
Start date: January 27, 2011
Phase:
Study type: Observational

The purpose of this study is to further quantify the risk of cerebrovascular events (CVEs) following sipuleucel-T (PROVENGE®) therapy, and to follow all subjects for survival.

NCT ID: NCT01078545 Completed - Clinical trials for Lower Urinary Tract Symptoms

Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)

LEMON
Start date: September 2008
Phase: N/A
Study type: Observational

The purpose of the study is to determine the influence of GnRH (gonadotropin releasing hormone) analogue - Lucrin Depot 11.25 mg (Lucrin Depot 3.75mg - in Ukraine) administration on intensity of lower urinary tract symptoms (LUTS) in patients with diagnosed locally advanced and/or metastatic prostate cancer and LUTS.

NCT ID: NCT00871585 Completed - Clinical trials for Advanced Prostate Cancer

Evaluation of Prostate-Specific Antigen (PSA) Levels in Patients With Advanced Prostate Cancer Treated With Bicalutamide

Start date: March 2009
Phase: N/A
Study type: Observational

Prospective, non-comparative, non-interventional, observational study to collect and analyse real life environment data on advanced prostate cancer patients receiving combination treatment of medical or surgical castration and bicalutamide according to routine medical practice in Croatia. The main aim is to evaluate change of PSA level and prescribing practices based on prostate cancer stage.